Is Nyxoah Making Waves in the Healthcare Stock Sector?

2 min read | December 13, 2024 12:18 AM PST | By Team Kalkine Media

Google News:

Is Nyxoah Making Waves in the Healthcare Stock Sector? — Image source: Shutterstock

Recent News

JPMorgan (NYSE:JPM) Leads Quiet Rotation In Financial Value Stocks

Exxon Mobil (NYSE:XOM) In Focus: What’s Catching Market Attention?

UnitedHealth (NYSE:UNH) Leads Healthcare Value Watch

Duke Energy (NYSE:DUK) Dividends Face A Key Market Test

Make Kalkine Media
My Trusted Source

Highlights:

Nyxoah launches Genio system commercially in England

Initial implants carried out at University College London Hospitals

System included in NHS Specialised Services Devices Programme

The healthcare sector continues to evolve with advancements in medical technologies aimed at improving patient outcomes. Innovations in this field address various medical conditions, enhancing the quality of life for individuals worldwide.

Genio System Launch

Nyxoah (NASDAQ:NYXH) has introduced its Genio system to the English market, marking a significant milestone in the treatment of Obstructive Sleep Apnea (OSA). The Genio system utilizes neuromodulation technology to address the underlying causes of OSA, offering a novel approach within the medical device landscape.

Implementation at University College London Hospitals

University College London Hospitals (UCLH) has been the venue for the initial deployment of the Genio system. The surgical procedures were performed by Mr. Ryan Chin Taw Cheong, a Consultant ENT and Sleep Surgeon at UCLH. This collaboration underscores the system's integration into established healthcare institutions, facilitating its adoption by medical professionals.

Inclusion in NHS Specialised Services Devices Programme

The Genio system has been incorporated into the NHS Specialised Services Devices Programme (SSDP). This inclusion ensures that the system is accessible to patients through the National Health Service, highlighting its acceptance and endorsement within the UK healthcare framework.

Neuromodulation for OSA Treatment

Neuromodulation represents a cutting-edge technique in managing Obstructive Sleep Apnea. By targeting specific neural pathways, the Genio system effectively mitigates the symptoms associated with OSA. This method provides an alternative to traditional treatments, offering a less invasive option for patients seeking relief from sleep apnea.

Nyxoah's Expansion in the UK Market

The commercial launch of the Genio system in England signifies Nyxoah's strategic expansion within the UK healthcare market. This development reflects the company's commitment to providing innovative solutions for sleep-related disorders and reinforces its position in the medical device industry.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.